Positioning of a polymorphic quantitative trait nucleotide in the ncf1 gene controlling oxidative burst response and arthritis severity in rats

Antioxidants and Redox Signaling

Volumn 14, Issue 12, 2011, Pages 2373-2383

  Hultqvist, Malin ^a,b   Sareila, Outi ^c   Vilhardt, Frederik ^d   Norin, Ulrika ^e   Olsson, Lina M ^a   Olofsson, Peter ^f   Hellman, Ulf ^g   Holmdahl, Rikard ^a,c,e  

^a LUND UNIVERSITY   (Sweden)

^b Redoxis AB   (Sweden)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e KAROLINSKA INSTITUTE   (Sweden)

^f Redoxis AB   (Sweden)

^g UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; LENTIVIRUS VECTOR; NUCLEOTIDE; QUANTITATIVE TRAIT NUCLEOTIDE; REACTIVE OXYGEN METABOLITE; SERINE; THREONINE; UNCLASSIFIED DRUG;

ALLELE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTHRITIS; ARTICLE; CYTOSOL; DISEASE SEVERITY; GENE; GENE CONTROL; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GENOTYPE; GRANULOCYTE; IMMUNOPRECIPITATION; MUTATIONAL ANALYSIS; NCF1 GENE; NONHUMAN; PHAGOSOME; PHOSPHORYLATION; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; RAT; RESPIRATORY BURST; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING; WISTAR RAT;

ANIMALS; ARTHRITIS; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; NADPH OXIDASE; PHAGOSOMES; PHOSPHOPROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RESPIRATORY BURST;

RATTUS;

EID: 79957475372     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3440     Document Type: Article

References (67)

1. Ago T, Nunoi H, Ito T, and Sumimoto H. Mechanism for phosphorylation- induced activation of the phagocyte NADPH oxidase protein p47(phox). Triple replacement of serines 303, 304, and 328 with aspartates disrupts the SH3 domain-mediated intramolecular interaction in p47(phox), thereby activating the oxidase. J Biol Chem 274: 33644-33653, 1999. (Pubitemid 129511677)
2. Ago T, Takeya R, Hiroaki H, Kuribayashi F, Ito T, Kohda D, and Sumimoto H. The PX domain as a novel phosphoinositide- binding module. Biochem Biophys Res Commun 287: 733-738, 2001. (Pubitemid 32912776)
3. Ahlqvist E, Hultqvist M, and Holmdahl R. The value of animal models in predicting genetic susceptibility to complex diseases such as rheumatoid arthritis. Arthritis Res Ther 11: 226, 2009.
4. Aitman TJ, Critser JK, Cuppen E, Dominiczak A, Fernandez- Suarez XM, Flint J, Gauguier D, Geurts AM, Gould M, Harris PC, Holmdahl R, Hubner N, Izsvak Z, Jacob HJ, Kuramoto T, Kwitek AE, Marrone A, Mashimo T, Moreno C, Mullins J, Mullins L, Olsson T, Pravenec M, Riley L, Saar K, Serikawa T, Shull JD, Szpirer C, Twigger SN, Voigt B, and Worley K. Progress and prospects in rat genetics: a community view. Nat Genet 40: 516-522, 2008. (Pubitemid 351601225)
5. Antonell A, de Luis O, Domingo-Roura X, and Perez-Jurado LA. Evolutionary mechanisms shaping the genomic structure of the Williams-Beuren syndrome chromosomal region at human 7q11.23. Genome Res 15: 1179-1188, 2005. (Pubitemid 41247908)
6. Babior BM. NADPH oxidase: an update. Blood 93: 1464-1476, 1999. (Pubitemid 29102471)
7. Babior BM, Lambeth JD, and Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 397: 342-344, 2002. (Pubitemid 34852301)
8. Bauer K, Yu X, Wernhoff P, Koczan D, Thiesen HJ, and Ibrahim SM. Identification of new quantitative trait loci in mice with collagen-induced arthritis. Arthritis Rheum 50: 3721-3728, 2004. (Pubitemid 39488702)
9. Bayes M, Magano LF, Rivera N, Flores R, and Perez Jurado LA. Mutational mechanisms of Williams-Beuren syndrome deletions. Am J Hum Genet 73: 131-151, 2003. (Pubitemid 36793786)
10. Becanovic K, Jagodic M, Sheng JR, Dahlman I, Aboul-Enein F, Wallstrom E, Olofsson P, Holmdahl R, Lassmann H, and Olsson T. Advanced intercross line mapping of Eae5 reveals Ncf-1 and CLDN4 as candidate genes for experimental autoimmune encephalomyelitis. J Immunol 176: 6055-6064, 2006.
11. Bedard K and Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313, 2007. (Pubitemid 46209993)
12. Bergsteinsdottir K, Yang HT, Pettersson U, and Holmdahl R. Evidence for common autoimmune disease genes controlling onset, severity, and chronicity based on experimental models for multiple sclerosis and rheumatoid arthritis. J Immunol 164: 1564-1568, 2000. (Pubitemid 30067274)
13. Brunsberg U, Gustafsson K, Jansson L, Michaelsson E, Ahrlund-Richter L, Pettersson S, Mattsson R, and Holmdahl R. Expression of a transgenic class II Ab gene confers susceptibility to collagen-induced arthritis. Eur J Immunol 24: 1698-1702, 1994. (Pubitemid 24203781)
14. Brunson T, Wang Q, Chambers I, and Song Q. A copy number variation in human NCF1 and its pseudogenes. BMC Genet 11: 13, 2010.
15. Burritt JB, Quinn MT, Jutila MA, Bond CW, and Jesaitis AJ. Topological mapping of neutrophil cytochrome b epitopes with phage-display libraries. J Biol Chem 270: 16974-16980, 1995.
16. Chanock SJ, el Benna J, Smith RM, and Babior BM. The respiratory burst oxidase. J Biol Chem 269: 24519-24522, 1994. (Pubitemid 24311695)
17. Dahlgren C and Karlsson A. Respiratory burst in human neutrophils. J Immunol Methods 232: 3-14, 1999. (Pubitemid 30017761)
18. de Mendez I, Homayounpour N, and Leto TL. Specificity of p47phox SH3 domain interactions in NADPH oxidase assembly and activation. Mol Cell Biol 17: 2177-2185, 1997. (Pubitemid 27133304)
19. Del Campo M, Antonell A, Magano LF, Munoz FJ, Flores R, Bayes M, and Perez Jurado LA. Hemizygosity at the NCF1 gene in patients with Williams-Beuren syndrome decreases their risk of hypertension. Am J Hum Genet 78: 533-542, 2006.
20. Dusi S, Della Bianca V, Grzeskowiak M, and Rossi F. Relationship between phosphorylation and translocation to the plasma membrane of p47phox and p67phox and activation of the NADPH oxidase in normal and Ca(2 + )-depleted human neutrophils. Biochem J 290 (Pt 1): 173-178, 1993. (Pubitemid 23081216)
21. El-Benna J, Dang PM, Gougerot-Pocidalo MA, Marie JC, and Braut-Boucher F. p47phox, the phagocyte NADPH oxidase/ NOX2 organizer: structure, phosphorylation and implication in diseases. Exp Mol Med 41: 217-225, 2009.
22. Freeman JL and Lambeth JD. NADPH oxidase activity is independent of p47phox in vitro. J Biol Chem 271: 22578-22582, 1996. (Pubitemid 26304697)
23. Gateva V, Sandling JK, Hom G, Taylor KE, Chung SA, Sun X, Ortmann W, Kosoy R, Ferreira RC, Nordmark G, Gunnarsson I, Svenungsson E, Padyukov L, Sturfelt G, Jonsen A, Bengtsson AA, Rantapaa-Dahlqvist S, Baechler EC, Brown EE, Alarcon GS, Edberg JC, Ramsey-Goldman R, McGwin G, Jr., Reveille JD, Vila LM, Kimberly RP, Manzi S, Petri MA, Lee A, Gregersen PK, Seldin MF, Ronnblom L, Criswell LA, Syvanen AC, Behrens TW, and Graham RR. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 41: 1228-1233, 2009.
24. Gelderman KA, Hultqvist M, Holmberg J, Olofsson P, and Holmdahl R. T cell surface redox levels determine T cell reactivity and arthritis susceptibility. Proc Natl Acad Sci USA 103: 12831-12836, 2006. (Pubitemid 44298647)
25. Gelderman KA, Hultqvist M, Pizzolla A, Zhao M, Nandakumar KS, Mattsson R, and Holmdahl R. Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. J Clin Invest 117: 3020-3028, 2007. (Pubitemid 47529631)
26. Glazier AM, Nadeau JH, and Aitman TJ. Finding genes that underlie complex traits. Science 298: 2345-2349, 2002. (Pubitemid 36014199)
27. Gregersen PK and Olsson LM. Recent advances in the genetics of autoimmune disease. Annu Rev Immunol 27: 363-391, 2009.
28. Groemping Y, Lapouge K, Smerdon SJ, and Rittinger K. Molecular basis of phosphorylation-induced activation of the NADPH oxidase. Cell 113: 343-355, 2003. (Pubitemid 36556116)
29. Groemping Y and Rittinger K. Activation and assembly of the NADPH oxidase: a structural perspective. Biochem J 386: 401-416, 2005. (Pubitemid 40445864)
30. Hellman U. Peptide mapping using MALDI-TOFMS. In: Mass Spectrometry and Hyphenated Techniques in Neuropeptide Research, edited by Silberring JaE, R. New York, NY: John Wiley & Sons, Inc., 2002, pp. 259-275.
31. Heyworth PG, Curnutte JT, Nauseef WM, Volpp BD, Pearson DW, Rosen H, and Clark RA. Neutrophil nicotinamide adenine dinucleotide phosphate oxidase assembly. Translocation of p47-phox and p67-phox requires interaction between p47- phox and cytochrome b558. J Clin Invest 87: 352-356, 1991.
32. Heyworth PG, Noack D, and Cross AR. Identification of a novel NCF-1 (p47-phox) pseudogene not containing the signature GT deletion: significance for A47 degrees chronic granulomatous disease carrier detection. Blood 100: 1845- 1851, 2002. (Pubitemid 34925165)
33. Holmdahl R, Carlsén S, Mikulowska A, Vestberg M, Brunsberg U, Hansson A, Sundvall M, Larsson L, and Pettersson U. Genetic analysis of mouse models for rheumatois arthritis. In: Human Genome Methods, edited by Adolph KW. New York, NY: CRC Press LLC, 1998, pp. 215-238.
34. Holmdahl R, Jansson L, Andersson M, and Larsson E. Immunogenetics of type II collagen autoimmunity and susceptibility to collagen arthritis. Immunology 65: 305-310, 1988.
35. Hultqvist M, Olofsson P, Gelderman KA, Holmberg J, and Holmdahl R. A new arthritis therapy with oxidative burst inducers. PLoS Med 3: e348, 2006.
36. Hultqvist M, Olofsson P, Holmberg J, Backstrom BT, Tordsson J, and Holmdahl R. Enhanced autoimmunity, arthritis, and encephalomyelitis in mice with a reduced oxidative burst due to a mutation in the Ncf1 gene. Proc Natl Acad Sci USA 101: 12646-12651, 2004. (Pubitemid 39122077)
37. Hultqvist M, Olsson LM, Gelderman KA, and Holmdahl R. The protective role of ROS in autoimmune disease. Trends Immunol 30: 201-208, 2009.
38. Ishihara H, Martin BL, Brautigan DL, Karaki H, Ozaki H, Kato Y, Fusetani N, Watabe S, Hashimoto K, Uemura D, et al. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem Biophys Res Commun 159: 871-877, 1989. (Pubitemid 19101063)
39. Karathanassis D, Stahelin RV, Bravo J, Perisic O, Pacold CM, Cho W, and Williams RL. Binding of the PX domain of p47(phox) to phosphatidylinositol 3,4-bisphosphate and phosphatidic acid is masked by an intramolecular interaction. EMBO J 21: 5057-5068, 2002.
40. Koshkin V, Lotan O, and Pick E. The cytosolic component p47(phox) is not a sine qua non participant in the activation of NADPH oxidase but is required for optimal superoxide production. J Biol Chem 271: 30326-30329, 1996.
41. Lambeth JD, Krause KH, and Clark RA. NOX enzymes as novel targets for drug development. Semin Immunopathol 30: 339-363, 2008.
42. Leto TL, Adams AG, and de Mendez I. Assembly of the phagocyte NADPH oxidase: binding of Src homology 3 domains to proline-rich targets. Proc Natl Acad Sci USA 91: 10650-10654, 1994. (Pubitemid 24329056)
43. Leusen JH, Bolscher BG, Hilarius PM, Weening RS, Kaulfersch W, Seger RA, Roos D, and Verhoeven AJ. 156Pro- > Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67- phox. J Exp Med 180: 2329-2334, 1994.
44. Lindqvist AK, Johannesson M, Johansson AC, Nandakumar KS, Blom AM, and Holmdahl R. Backcross and partial advanced intercross analysis of nonobese diabetic genemediated effects on collagen-induced arthritis reveals an interactive effect by two major loci. J Immunol 177: 3952-3959, 2006. (Pubitemid 44362962)
45. Lundqvist H and Dahlgren C. Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radic Biol Med 20: 785-792, 1996. (Pubitemid 26123853)
46. Nobuhisa I, Takeya R, Ogura K, Ueno N, Kohda D, Inagaki F, and Sumimoto H. Activation of the superoxide-producing phagocyte NADPH oxidase requires co-operation between the tandem SH3 domains of p47phox in recognition of a polyproline type II helix and an adjacent alpha-helix of p22phox. Biochem J 396: 183-192, 2006. (Pubitemid 43764510)
47. Ogura K, Nobuhisa I, Yuzawa S, Takeya R, Torikai S, Saikawa K, Sumimoto H, and Inagaki F. NMR solution structure of the tandem Src homology 3 domains of p47phox complexed with a p22phox-derived proline-rich peptide. J Biol Chem 281: 3660-3668, 2006. (Pubitemid 43845984)
48. Olofsson P, Holmberg J, Pettersson U, and Holmdahl R. Identification and isolation of dominant susceptibility loci for pristane-induced arthritis. J Immunol 171: 407-416, 2003. (Pubitemid 36745314)
49. Olofsson P, Holmberg J, Tordsson J, Lu S, Akerstrom B, and Holmdahl R. Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet 33: 25-32, 2003. (Pubitemid 36068678)
50. Olofsson P and Holmdahl R. Positional cloning of Ncf1-a piece in the puzzle of arthritis genetics. Scand J Immunol 58: 155-164, 2003. (Pubitemid 36904307)
51. Olsson LM, Lindqvist AK, Kallberg H, Padyukov L, Burkhardt H, Alfredsson L, Klareskog L, and Holmdahl R. A case-control study of Rheumatoid arthritis identifies an associated SNP in the NCF4 gene supporting a role for the NOX-complex in autoimmunity. Arthritis Res Ther 9: R98, 2007.
52. Price MO, McPhail LC, Lambeth JD, Han CH, Knaus UG, and Dinauer MC. Creation of a genetic system for analysis of the phagocyte respiratory burst: high-level reconstitution of the NADPH oxidase in a nonhematopoietic system. Blood 99: 2653-2661, 2002. (Pubitemid 34525349)
53. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, Huett A, Green T, Kuballa P, Barmada MM, Datta LW, Shugart YY, Griffiths AM, Targan SR, Ippoliti AF, Bernard EJ, Mei L, Nicolae DL, Regueiro M, Schumm LP, Steinhart AH, Rotter JI, Duerr RH, Cho JH, Daly MJ, and Brant SR. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39: 596-604, 2007. (Pubitemid 46676115)
54. Roepstorff K, Rasmussen I, Sawada M, Cudre-Maroux C, Salmon P, Bokoch G, van Deurs B, and Vilhardt F. Stimulusdependent regulation of the phagocyte NADPH oxidase by a VAV1, Rac1, and PAK1 signaling axis. J Biol Chem 283: 7983-7993, 2008.
55. Rothe G, Oser A, and Valet G. Dihydrorhodamine 123: a new flow cytometric indicator for respiratory burst activity in neutrophil granulocytes. Naturwissenschaften 75: 354-355, 1988.
56. Shen K, Sergeant S, Hantgan RR, McPhail LC, and Horita DA. Mutations in the PX-SH3A linker of p47phox decouple PI(3,4)P2 binding from NADPH oxidase activation. Biochemistry 47: 8855-8865, 2008.
57. Shiose A and Sumimoto H. Arachidonic acid and phosphorylation synergistically induce a conformational change of p47phox to activate the phagocyte NADPH oxidase. J Biol Chem 275: 13793-13801, 2000. (Pubitemid 30257452)
58. Sumimoto H, Hata K, Mizuki K, Ito T, Kage Y, Sakaki Y, Fukumaki Y, Nakamura M, and Takeshige K. Assembly and activation of the phagocyte NADPH oxidase. Specific interaction of the N-terminal Src homology 3 domain of p47phox with p22phox is required for activation of the NADPH oxidase. J Biol Chem 271: 22152-22158, 1996. (Pubitemid 26303847)
59. Sumimoto H, Kage Y, Nunoi H, Sasaki H, Nose T, Fukumaki Y, Ohno M, Minakami S, and Takeshige K. Role of Src homology 3 domains in assembly and activation of the phagocyte NADPH oxidase. Proc Natl Acad Sci USA 91: 5345-5349, 1994. (Pubitemid 24174323)
60. Taura M, Miyano K, Minakami R, Kamakura S, Takeya R, and Sumimoto H. A region N-terminal to the tandem SH3 domain of p47phox plays a crucial role in the activation of the phagocyte NADPH oxidase. Biochem J 419: 329-338, 2009.
61. van Bruggen R, Anthony E, Fernandez-Borja M, and Roos D. Continuous translocation of Rac2 and the NADPH oxidase component p67(phox) during phagocytosis. J Biol Chem 279: 9097-9102, 2004. (Pubitemid 38295974)
62. van der Helm-van Mil AH, Padyukov L, Toes RE, Klareskog L, and Huizinga TW. Genome-wide single-nucleotide polymorphism studies in rheumatology: Hype or hope? Arthritis Rheum 58: 2591-2597, 2008.
63. Vingsbo-Lundberg C, Nordquist N, Olofsson P, Sundvall M, Saxne T, Pettersson U, and Holmdahl R. Genetic control of arthritis onset, severity and chronicity in a model for rheumatoid arthritis in rats. Nat Genet 20: 401-404, 1998. (Pubitemid 28541644)
64. Vowells SJ, Sekhsaria S, Malech HL, Shalit M, and Fleisher TA. Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes. J Immunol Methods 178: 89-97, 1995.
65. Vutskits GV, Salmon P, Mayor L, Vutskits L, Cudre-Mauroux C, Soriano J, Montesano R, Maillet P, and Sappino AP. A role for atm in E-cadherin-mediated contact inhibition in epithelial cells. Breast Cancer Res Treat 99: 143-153, 2006. (Pubitemid 44268262)
66. Wooley PH, Luthra HS, Stuart JM, and David CS. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med 154: 688-700, 1981. (Pubitemid 11060781)
67. Young MA, Gonfloni S, Superti-Furga G, Roux B, and Kuriyan J. Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by Cterminal tyrosine phosphorylation. Cell 105: 115-126, 2001. (Pubitemid 32323921)